Le Lézard
Classified in: Health
Subjects: PDT, MAT

Maine Propels Cannabis Research Advancements at Brunswick Landing with Maridose Partnership


BRUNSWICK, Maine, Jan. 29, 2024 /PRNewswire/ -- Maridose, a leading Drug Enforcement Administration (DEA) Licensed Bulk Manufacturer of cannabis for research and a trailblazer in the cannabis industry, proudly announces the establishment of a Center of Excellence for Cannabis Research at Brunswick Landing, Maine. This expansion enhances the company's current location at Brunswick Landing increasing research capabilities and cultivating high-quality, research-grade cannabis for DEA-approved studies, with the ultimate goal of commercializing prescription drugs, non-prescription drugs, and dietary supplements.

Richard Shain, founder and visionary of Maridose, expressed his pride in the ongoing relationship and support from the State of Maine and MRRA, the operator of Brunswick Landing. Shain emphasized, "We are grateful for the continued collaboration with the State of Maine and MRRA, whose support has been instrumental in realizing our vision for advancing cannabis research."

Maridose recognizes the unique advantages of locating at TechPlace, Brunswick Landing's innovation center provides Maridose access to a collaborative environment fostering innovation, cutting-edge technologies, and a network of like-minded professionals. The synergy between Maridose's research endeavors and TechPlace's ecosystem positions the company at the forefront of cannabis research. The parties are convinced Maridose's expertise in developing cannabis-related pharmaceuticals and wellness products will also contribute to the growth of Maine's biotech community and the broader research industry.

Expansion funding for this transformative project is currently underway through a private placement managed by Young America Capital. This collaboration ensures that Maridose's vision for a Center of Excellence for Cannabis Research becomes a reality.

For media inquiries, please contact:
Richard Shain
[email protected]

About Maridose LLC

Maridose is a leading DEA-licensed biopharmaceutical research and product development company focused on cannabis and cannabis-derived products. The company was selected by the U.S. DOJ and DEA to legally cultivate and sell cannabis. Maridose's Center of Excellence is located in Brunswick Landing, Maine providing best-in-class cannabis cultivation, research and product development.

About TechPlace, Brunswick Landing

TechPlace at Brunswick Landing is an innovation hub fostering collaboration and cutting-edge research. This dynamic ecosystem provides Maridose with state-of-the-art facilities and a vibrant community, positioning the company at the forefront of cannabis research. For more information, visit https://brunswicklanding.us/techplace-maines-technology-incubator/ 

SOURCE Maridose LLC


These press releases may also interest you

at 10:53
The Alliance for Healthier Communities and the Older Adult Centres Association of Ontario are pleased to announce additional funding from an anonymous donor to continue their partnership on Phase 2 of the Links2Wellbeing (L2W) Social Prescribing for...

at 10:45
According to new research, an innovative technology from Chicago-based Hydrosome Labs is poised to solve multiple problems faced in precision fermentation, a process that involves the customization of yeast and/or bacteria to produce specific...

at 10:45
Digestive Health Specialists (DHS) is proud to announce its 25th anniversary of providing patient centric digestive health services to the Northern Mississippi community. Since 1999, DHS has remained committed to delivering exceptional care and...

at 10:45
"I'm currently a physician and previously was employed as a phlebotomist, and I wanted to create an improved butterfly needle/winged infusion set," said an inventor, from Latham, N.Y., "so I invented the Z- LOK BUTTERFLY NEEDLE. My design allows for...

at 10:39
The EveryLife Foundation for Rare Diseases is excited to announce its Scientific Workshop slated for May 21, 2024, in Washington, D.C., with both virtual and in-person attendance options....

at 10:35
Bruker Corporation will host an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time (EDT) tomorrow May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business....



News published on and distributed by: